[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Study Finds Increased Lung Cancer Risk Following Treatment fo r Hodgkin's Disease
Howard,
What are you talking about? What does this have to do with the Iowa study?
What threshold are you talking about? The minimum treatment?
-- John
John Jacobus, MS
Certified Health Physicist
3050 Traymore Lane
Bowie, MD 20715-2024
E-mail: jenday1@email.msn.com (H)
-----Original Message-----
From: hflong@postoffice.pacbell.net
[mailto:hflong@postoffice.pacbell.net]
Sent: Wednesday, February 06, 2002 3:57 PM
To: Dukelow, James S Jr
Cc: Jacobus, John (OD/ORS); RadSafe
Subject: Re: Study Finds Increased Lung Cancer Risk Following Treatment
fo r Hodgkin's Disease
Cancer threshold?
As in the Iowa study, apparently "controls" here were different from cases
in ways that could explain association without the implied causality. In
Iowa, it was smoking (only 32% of controls). Here, sicker Hodgkin's Disease
patients would seem more likely to receive radiation, chemotherapy, and
especially both - and these are the very patients more likely to get other
cancers, (with or without the treatment, implied here to cause the other
cancer).
Common Cause.
Above threshold dose also says nothing about rate of cancer with below
threshold dose (an argument you've seen before here).
Only double-blind, placebo studies should imply "cause".
Others, like this one, are more accurately, "suggestive".
Howard Long
"Dukelow, James S Jr" wrote:
> John Jacobus passed along to us:
> -----Original Message-----
> From: Jacobus, John (OD/ORS) [mailto:jacobusj@ors.od.nih.gov]
> Sent: Wednesday, February 06, 2002 9:21 AM
> To: RadSafe
> Subject: Study Finds Increased Lung Cancer Risk Following Treatment for
> Ho dgkin's Disease
>
> I received this from another mailing list and thought I would pass it
along.
>
> -- John
>
> <snip>
>
> National Institutes of Health:
> NCI Press Office (301) 496-6641
> EMBARGOED FOR RELEASE
> 4pm EST
> Tuesday, February 5, 2002
>
> Study Finds Increased Lung Cancer Risk Following
> Treatment for Hodgkin's Disease
>
> People with Hodgkin's disease (HD) who receive
> chemotherapy, radiotherapy, or a combination of the two
> treatments, are at higher risk of developing lung cancer,
> according to a report in the Feb. 6, 2002, issue of the
> Journal of the National Cancer Institute.* The study also
> finds a higher risk for lung cancer among smokers treated
> with both radiotherapy and chemotherapy.
>
> "It was the combined effect of smoking and treatment that
> accounted for the bulk of lung cancers in this study,
> underscoring the importance of smoking cessation in the
> management of patients with Hodgkin's disease," the
> authors conclude. "It is clear that the tremendous
> improvement in the treatment of HD far outweighs any
> therapy-related risks of lung cancers, especially when
> compared with the enormous burden imposed by tobacco,"
> said Lois Travis, M.D., Sc.D., of the National Cancer
> Institute's Division of Cancer Epidemiology and Genetics
> in Bethesda, Md., and first author of the study.
>
> <snip>
>
> For this study, the researchers looked at many different
> factors, but focused on three main measures: the type and
> cumulative amount of chemotherapy drugs, the radiation
> dose, and tobacco use. All three exposures contributed
> significantly to elevated lung cancer risks. Tobacco use,
> chemotherapy, and radiotherapy doses of five Gray (Gy) or
> more were reported in 96 percent, 63 percent, and 53
> percent of case subjects (those who developed lung
> cancer), respectively, and in 70 percent, 52 percent, and
> 41 percent of patients who did not develop lung cancer.
>
> Subjects who received either radiotherapy alone or
> chemotherapy with drugs called alkylating agents
> experienced a significantly increased risk of lung cancer.
> And when researchers looked at the group of patients who
> received both alkylating agents and radiotherapy, the
> numbers showed risks that were additive.
>
> <snip>
>
> =================
>
> Jim Dukelow comments:
>
> Something is strange here -- or, perhaps, I am missing something.
>
> It is reported that of the 444 control subjects (all of whom had been
> treated for HD and had not developed lung cancer), 52% are reported to
have
> had chemotherapy and 41% reported to have had radiotherapy. And the
missing
> 7% -- "Take two aspirin and call me in the morning"?
>
> Also, the press release talks about patients who received radiotherapy
ALONE
> or chemotherapy with drugs called alkylating agents [with an implied ALONE
> there also] having so much of a risk increase. This is disingenuous,
since
> 96% of the "cases" -- those with lung cancer -- were smokers.
>
> Best regards.
>
> Jim Dukelow
> Pacific Northwest National Laboratory
> Richland, WA
> jim.dukelow@pnl.gov
>
> These comments are mine and have not been reviewed and/or approved by my
> management or by the U.S. Department of Energy.
> ************************************************************************
> You are currently subscribed to the Radsafe mailing list. To unsubscribe,
> send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
> radsafe" (no quote marks) in the body of the e-mail, with no subject line.
You can view the Radsafe archives at http://www.vanderbilt.edu/radsafe/
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line. You can view the Radsafe archives at http://www.vanderbilt.edu/radsafe/